COMMUNIQUÉS West-GlobeNewswire

Eve & Co Announces Upgraded United States Listing to OTCQX from OTCQB
21/06/2019
TORONTO, June 21, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQX: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that its common shares will be listed for trading on the OTCQX [...]
PCI Biotech: Employee share option scheme
21/06/2019
Oslo, 21 June 2019 In accordance with the authorisation granted by the Annual General Meeting 29 May 2019, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 320,000 share options to key employees [...]
Wildflower Featured in NetworkNewsWire Publication Summarizing Amazing Profits Found in Cannabis
21/06/2019
NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial [...]
Generex Announces That the Pool Shares for the Benefit of Generex Will Be Retired and Put Back into the Corporate Treasury Following Payment of the 1:1 Dividend
21/06/2019
MIRAMAR, Fla., June 21, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the “Pool” shares controlled for [...]
REPEAT - AgraFlora Organics Secures 51,500 Sq. Ft Edibles Manufacturing Facility; Anticipates Q1 2020 Receipt of Health Canada Sales and Processing Licenses
21/06/2019
VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Immutep Announces Australian Patent Granted for Eftilagimod Alpha in Chemo-Immunotherapy
21/06/2019
SYDNEY, Australia, June 21, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Allena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria Workshop
21/06/2019
NEWTON, Mass., June 21, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Iterum Therapeutics to Present Data on Uncomplicated Urinary Tract Infections at ASM Microbe 2019
21/06/2019
Limited options remain for successful empiric treatment of uncomplicated urinary tract infections (uUTIs) in the community DUBLIN, Ireland and CHICAGO, June 21, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: [...]
Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China
21/06/2019
SAN FRANCISCO, June 21, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Applied Therapeutics Reports First Quarter 2019 Financial Results
21/06/2019
-Strengthened Financial Position with Recent Initial Public Offering- - Phase 1/2 Trial AT-007 in Adults with Galactosemia Expected to Start This Month - - Pivotal Phase 2/3 Trial for AT-001 in Diabetic Cardiomyopathy [...]
Nabriva Therapeutics to Present Data at ASM Microbe Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin) for injection to Treat Complicated Urinary Tract Infections (cUTIs)
21/06/2019
DUBLIN, Ireland, June 21, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Fête nationale du Québec
21/06/2019
L’alcool, une arme redoutable à double tranchant pour la santé MONTRÉAL, 21 juin 2019 (GLOBE NEWSWIRE) -- À l’approche de la Fête nationale du Québec , la Fondation de l’Institut de Cardiologie de Montréal fait le point [...]
AgraFlora Organics Secures 51,500 Sq. Ft Edibles Manufacturing Facility; Anticipates Q1 2020 Receipt of Health Canada Sales and Processing Licenses
21/06/2019
VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Zealand Pharma introduces new website to support people living with short bowel syndrome
21/06/2019
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome, drawing from [...]
Wildflower mise en avant dans la publication de NetworkNewsWire soulignant les bénéfices incroyables générés par le cannabis
21/06/2019
NEW YORK, 21 juin 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) a annoncé aujourd'hui son apparition dans une rubrique éditoriale publiée par NetworkNewsWire (« NNW »), [...]
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma
21/06/2019
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma REGN3500 (SAR440340) monotherapy significantly reduced loss of asthma control and improved lung function compared to placebo [...]
Sanofi et Regeneron annoncent les premiers résultats positifs de phase II de leur anticorps anti-IL-33 dans le traitement de l’asthme
21/06/2019
Sanofi et Regeneron annoncent les premiers résultats positifs de phase II de leur anticorps anti-IL-33 dans le traitement de l’asthme REGN3500 (SAR440340) en monothérapie a significativement réduit le risque de perte de [...]
ObsEva SA to Present Nolasiban and Linzagolix Clinical Data at the ESHRE Annual Meeting June 23-26 in Vienna
21/06/2019
Geneva, Switzerland and Boston, MA – June 21, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
21/06/2019
Regulated information Gosselies, Belgium, 21 June 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]

Pages